Therapeutic targeting of SPIB/SPI1‐facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progression
Clinical and Translational Medicine2021Vol. 11(11), pp. e588–e588
Citations Over TimeTop 10% of 2021 papers
Jianqun Wang, Xiaojing Wang, Yanhua Guo, Lin Ye, Dan Li, Anpei Hu, Shuang Cai, Boling Yuan, Shikai Jin, Yi Zhou, Qilan Li, Liduan Zheng, Qiangsong Tong
Abstract
Therapeutic targeting of SPIB/SPI1-facilitated interplay of cancerous cells and neutrophils suppresses aerobic glycolysis and progression of cancer.
Related Papers
- → Impairment of Aerobic Glycolysis by Inhibitors of Lactic Dehydrogenase Hinders the Growth of Human Hepatocellular Carcinoma Cell Lines(2010)60 cited
- → Oncogenic virus-induced aerobic glycolysis and tumorigenesis(2018)37 cited
- Role of the Intracellular pH in the Metabolic Switch between Oxidative Phosphorylation and Aerobic Glycolysis - Relevance to Cancer(2011)
- [Involvement of K+ in anerobic glycolysis of E. coli].(1982)
- → Aerobic Glycolysis and Its Role in Maintenance of High O2 Tensions in the Teleost Retina(1971)9 cited